Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gautier Marcq

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
Urologic Oncology|December 7, 2020
Refining assessment of response to radiation-based therapy for muscle-invasive bladder cancer: Is post-treatment tumor bed biopsy always necessary?Ronald Kool, Gautier Marcq, Adnan El-Achkar, et al.
European Urology Open Science|January 31, 2022
Role of Serum Lymphocyte-derived Biomarkers in Nonmetastatic Muscle-invasive Bladder Cancer Patients Treated with Trimodal TherapyRonald Kool, Gautier Marcq, Surashri Shinde-Jadhav, et al.
Urology|June 30, 2025
Effect of Sex Differences on Cancer Outcomes After Chemo-Radiation for Muscle-Invasive Bladder Cancer: A Retrospective Multicenter Cohort StudyIain MacIntyre, Ronald Kool, Gautier Marcq, et al.
European Urology Oncology|August 2, 2025
The Evolving Landscape of Systemic Immunotherapy for Bacillus Calmette-Guérin-naïve High-risk Non-muscle-invasive Bladder Cancer: At the Edge of a Tsunami?Pierre-Etienne Gabriel, Mathieu Roumiguié, Gautier Marcq, et al.
European Urology|September 12, 2024
Tissue-based Biomarkers Steering Clinical Decisions in Patients with Urothelial CancerLuca Afferi, Alessia Cimadamore, Andrea Gallioli, et al.
The French Journal of Urology|November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Upper urinary tract urothelial cancer (UTUC)Mathieu Roumiguié, Thomas Seisen, Alexandra Masson-Lecomte, et al.
The French Journal of Urology|November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Non-muscle invasive bladder cancer (NMIBC)Mathieu Roumiguié, Priscilla Leon, Evanguelos Xylinas, et al.
The French Journal of Urology|November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Muscle-invasive bladder cancer (MIBC)Mathieu Roumiguié, Gautier Marcq, Yann Neuzillet, et al.
World Journal of Urology|January 13, 2026
Surgical outcomes after neoadjuvant avelumab with or without chemotherapy for Muscle-Invasive bladder cancer: a Post-Hoc analysis of the aura trial (Oncodistinct-004)Georges Mjaess, Thierry Quackels, Jean-Christophe Fantoni, et al.
The French Journal of Urology|October 19, 2025
French recommendations of the AFU Oncology Committee for Bladder Cancer: Update 2025Mathieu Roumiguié, Evanguelos Xylinas, Pierre Etienne Gabriel, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Urologic Oncology|December 7, 2020
Refining assessment of response to radiation-based therapy for muscle-invasive bladder cancer: Is post-treatment tumor bed biopsy always necessary?Ronald Kool, Gautier Marcq, Adnan El-Achkar, et al.
European Urology Open Science|January 31, 2022
Role of Serum Lymphocyte-derived Biomarkers in Nonmetastatic Muscle-invasive Bladder Cancer Patients Treated with Trimodal TherapyRonald Kool, Gautier Marcq, Surashri Shinde-Jadhav, et al.
Urology|June 30, 2025
Effect of Sex Differences on Cancer Outcomes After Chemo-Radiation for Muscle-Invasive Bladder Cancer: A Retrospective Multicenter Cohort StudyIain MacIntyre, Ronald Kool, Gautier Marcq, et al.
European Urology Oncology|August 2, 2025
The Evolving Landscape of Systemic Immunotherapy for Bacillus Calmette-Guérin-naïve High-risk Non-muscle-invasive Bladder Cancer: At the Edge of a Tsunami?Pierre-Etienne Gabriel, Mathieu Roumiguié, Gautier Marcq, et al.
European Urology|September 12, 2024
Tissue-based Biomarkers Steering Clinical Decisions in Patients with Urothelial CancerLuca Afferi, Alessia Cimadamore, Andrea Gallioli, et al.
The French Journal of Urology|November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Upper urinary tract urothelial cancer (UTUC)Mathieu Roumiguié, Thomas Seisen, Alexandra Masson-Lecomte, et al.
The French Journal of Urology|November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Non-muscle invasive bladder cancer (NMIBC)Mathieu Roumiguié, Priscilla Leon, Evanguelos Xylinas, et al.
The French Journal of Urology|November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Muscle-invasive bladder cancer (MIBC)Mathieu Roumiguié, Gautier Marcq, Yann Neuzillet, et al.
World Journal of Urology|January 13, 2026
Surgical outcomes after neoadjuvant avelumab with or without chemotherapy for Muscle-Invasive bladder cancer: a Post-Hoc analysis of the aura trial (Oncodistinct-004)Georges Mjaess, Thierry Quackels, Jean-Christophe Fantoni, et al.
The French Journal of Urology|October 19, 2025
French recommendations of the AFU Oncology Committee for Bladder Cancer: Update 2025Mathieu Roumiguié, Evanguelos Xylinas, Pierre Etienne Gabriel, et al.
Pageof 10